Home > Insider Trading > Filing (0001179110-15-008396)

Filing Details

Accession Number:: 0001179110-15-008396
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-05-21 18:30:30
Reporting Period:: 2015-05-19

Filing Date:: 2015-05-21
Accepted Time:: 2015-05-21 18:30:30
Original Submission Date:: 2015-05-21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1423824	Alder Biopharmaceuticals Inc	ALDR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033501	M Stephen Dow	C/O Sevin Rosen Funds 13355 Noel Road, Suite 1350 Dallas TX 75240		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-05-20	8,462	$40.39	4,313,992	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right To Buy)	Acquisiton	2015-05-19	6,350	$0.00	6,350	$39.66

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,350		2025-05-18	No	4	A	Direct

Footnotes

This Form 4 Amendment is being filed to replace in total the Form 4 filed earlier today on behalf of Steve Dow for Alder BioPharmaceuticals, Inc. An incorrect CIK code was used which resulted in the error.
Represents 8,462 Common Shares sold directly by Sevin Rosen Bayless Management Company ("SRBMC") pursuant to Rule 144 under the Securities Act of 1933, as amended.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.7025, inclusive. Information can be provided to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Total Common Shares of 4,313,992 represents 3,947,770 shares owned directly by Sevin Rosen Fund IX L.P., ("SRFIX"), 101,104 shares owned directly by Sevin Rosen IX Affiliates Fund L.P. ("SRIX AFF") and 265,118 shares owned directly by The Dow Family Trust the ("Dow Trust"). Reporting person is a member of the general partner of SRFIX and SRIX AFF, and as a member is deemed to have shared voting and dispositive power of the shares held by SRFIX and SRIX AFF, and disclaims beneficial ownership except to the extent of his proportionate interest in these shares. Reporting person is a director of SRBMC and is deemed to have shared voting and dispositive power of these shares and disclaims beneficial ownership with no pecuniary interest in these shares. Reporting person is a trustee of the Dow Trust.
This option was issued to the reporting person pursuant to the Issuer's 2014 Equity Incentive Plan and is effective immediately following the Issuer's Annual Meeting of Stockholders.
Options fully vest and become exercisable on the date of the 2016 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date.